Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 2/2019

01-02-2019 | Original Article

Quality of care in hospitalized cancer patients before and after implementation of a systematic prevention program for delirium: the DELTA exploratory trial

Authors: Asao Ogawa, Yasuyuki Okumura, Daisuke Fujisawa, Hiroyuki Takei, Chiyuki Sasaki, Kei Hirai, Yusuke Kanno, Kensuke Higa, Yasuhiko Ichida, Asuko Sekimoto, Chie Asanuma

Published in: Supportive Care in Cancer | Issue 2/2019

Login to get access

Abstract

Background

We evaluated whether the DELirium Team Approach (DELTA) program—a systematic management program aimed at screening high-risk groups and preventing delirium—would improve quality of care in patients hospitalized with cancer.

Methods

A retrospective before–after study was conducted during a pre-intervention period (between October 2012 and March 2013) and a post-intervention period (between October 2013 and March 2014) at a Japanese hospital providing specialized treatments for cancer. A total of 4180 inpatients were evaluated before the implementation of the DELTA program and 3797 inpatients were evaluated after implementation.

Results

After program implementation, the incidence of delirium decreased from 7.1 to 4.3% (odds ratio [OR], 0.52; 95% CI, 0.42–0.64). The incidence of adverse events, including falls or self-extubation, also decreased, from 3.5 to 2.6% (OR, 0.71; 95% CI, 0.54–0.92). There was a significant decrease in the prescription of benzodiazepines (OR, 0.79; 95% CI, 0.71–0.87), increase in the level of independence in activities of daily living at discharge (OR, 1.94; 95% CI, 1.11–3.38), and decrease in the length of stay (risk ratio 0.90; 95% CI, 0.90–0.90).

Conclusions

The systematic management program for delirium decreased the incidence of delirium and improved several clinical outcomes. These data suggest that this simple cost-effective program is feasible and implementable as routine care in busy wards.
Literature
1.
Akunne A, Murthy L, Young J (2012) Cost-effectiveness of multi-component interventions to prevent delirium in older people admitted to medical wards. Age Ageing 41:285–291CrossRef
2.
Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 46:399–424CrossRef
3.
Barker AL, Morello RT, Wolfe R, Brand CA, Haines TP, Hill KD, Brauer SG, Botti M, Cumming RG, Livingston PM, Sherrington C, Zavarsek S, Lindley RI, Kamar J (2016) 6-PACK programme to decrease fall injuries in acute hospitals: cluster randomised controlled trial. BMJ 352:h6781CrossRef
4.
Board INC (2011) Report of the International Narcotics Control Board on the availability of internationally controlled drugs: ensuring adequate access for medical and scientific purposes. In: Editor (ed)^(eds) Book Report of the International Narcotics Control Board on the availability of internationally controlled drugs: ensuring adequate access for medical and scientific purposes. International Narcotics Control Board, United Nations, City
5.
Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S, Lund S, Jacobson P (1996) A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153:231–237CrossRef
6.
Centeno C, Sanz A, Bruera E (2004) Delirium in advanced cancer patients. Palliat Med 18:184–194CrossRef
7.
Coyle MA, Burns P, Traynor V (2017) Is it my job? The role of RNs in the assessment and identification of delirium in hospitalized older adults: an exploratory qualitative study. J Gerontol Nurs 43:29–37CrossRef
8.
Dubois MJ, Bergeron N, Dumont M, Dial S, Skrobik Y (2001) Delirium in an intensive care unit: a study of risk factors. Intensive Care Med 27:1297–1304CrossRef
9.
Excellence NIfHaC (2010) Delirium: prevention, diagnosis and management. In: editor (ed)^(eds) Book delirium: prevention, diagnosis and management, City
10.
Gagnon P, Allard P, Gagnon B, Merette C, Tardif F (2012) Delirium prevention in terminal cancer: assessment of a multicomponent intervention. Psychooncology 21:187–194CrossRef
11.
Gamberini M, Bolliger D, Lurati Buse GA, Burkhart CS, Grapow M, Gagneux A, Filipovic M, Seeberger MD, Pargger H, Siegemund M, Carrel T, Seiler WO, Berres M, Strebel SP, Monsch AU, Steiner LA (2009) Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery—a randomized controlled trial. Crit Care Med 37:1762–1768CrossRef
12.
Girard TD, Pandharipande PP, Carson SS, Schmidt GA, Wright PE, Canonico AE, Pun BT, Thompson JL, Shintani AK, Meltzer HY, Bernard GR, Dittus RS, Ely EW, Investigators MT (2010) Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med 38:428–437CrossRef
13.
Gurlit S, Mollmann M (2008) How to prevent perioperative delirium in the elderly? Z Gerontol Geriatr 41:447–452CrossRef
14.
Hakim SM, Othman AI, Naoum DO (2012) Early treatment with risperidone for subsyndromal delirium after on-pump cardiac surgery in the elderly: a randomized trial. Anesthesiology 116:987–997CrossRef
15.
Hatta K, Kishi Y, Wada K, Takeuchi T, Odawara T, Usui C, Nakamura H, Group D-J (2014) Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry 71:397–403CrossRef
16.
Hempenius L, Slaets JP, van Asselt D, de Bock GH, Wiggers T, van Leeuwen BL (2013) Outcomes of a geriatric liaison intervention to prevent the development of postoperative delirium in frail elderly cancer patients: report on a multicentre, randomized, controlled trial. PLoS One 8:e64834CrossRef
17.
Hosie A, Davidson PM, Agar M, Sanderson CR, Phillips J (2013) Delirium prevalence, incidence, and implications for screening in specialist palliative care inpatient settings: a systematic review. Palliat Med 27:486–498CrossRef
18.
Hshieh TT, Yue J, Oh E, Puelle M, Dowal S, Travison T, Inouye SK (2015) Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis. JAMA Intern Med 175:512–520CrossRef
19.
20.
Inouye SK, Bogardus ST Jr, Charpentier PA, Leo-Summers L, Acampora D, Holford TR, Cooney LM Jr (1999) A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340:669–676CrossRef
21.
Inouye SK, Leo-Summers L, Zhang Y, Bogardus ST Jr, Leslie DL, Agostini JV (2005) A chart-based method for identification of delirium: validation compared with interviewer ratings using the confusion assessment method. J Am Geriatr Soc 53:312–318CrossRef
22.
Inouye SK, Brown CJ, Tinetti ME (2009) Medicare nonpayment, hospital falls, and unintended consequences. N Engl J Med 360:2390–2393CrossRef
23.
Inouye SK, Westendorp RG, Saczynski JS (2014) Delirium in elderly people. Lancet 383:911–922CrossRef
24.
Kalisvaart KJ, de Jonghe JF, Bogaards MJ, Vreeswijk R, Egberts TC, Burger BJ, Eikelenboom P, van Gool WA (2005) Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 53:1658–1666CrossRef
25.
Korc-Grodzicki B, Sun SW, Zhou Q, Iasonos A, Lu B, Root JC, Downey RJ, Tew WP (2015) Geriatric assessment as a predictor of delirium and other outcomes in elderly patients with cancer. Ann Surg 261:1085–1090CrossRef
26.
Lakatos BE, Capasso V, Mitchell MT, Kilroy SM, Lussier-Cushing M, Sumner L, Repper-Delisi J, Kelleher EP, Delisle LA, Cruz C, Stern TA (2009) Falls in the general hospital: association with delirium, advanced age, and specific surgical procedures. Psychosomatics 50:218–226CrossRef
27.
Larsen KA, Kelly SE, Stern TA, Bode RH Jr, Price LL, Hunter DJ, Gulczynski D, Bierbaum BE, Sweeney GA, Hoikala KA, Cotter JJ, Potter AW (2010) Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized, controlled trial. Psychosomatics 51:409–418CrossRef
28.
Leslie DL, Marcantonio ER, Zhang Y, Leo-Summers L, Inouye SK (2008) One-year health care costs associated with delirium in the elderly population. Arch Intern Med 168:27–32CrossRef
29.
Ljubisavljevic V, Kelly B (2003) Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry 25:345–352CrossRef
30.
Long JS (1997) Regression models for categorical and limited dependent variables. Sage, Thousand Oaks
31.
Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index Maryland state medical journal, vol 14, pp 61–65
32.
Marcantonio ER, Flacker JM, Wright RJ, Resnick NM (2001) Reducing delirium after hip fracture: a randomized trial. J Am Geriatr Soc 49:516–522CrossRef
33.
Martin BJ, Buth KJ, Arora RC, Baskett RJ (2010) Delirium as a predictor of sepsis in post-coronary artery bypass grafting patients: a retrospective cohort study. Crit Care 14:R171CrossRef
34.
McCusker J, Cole M, Abrahamowicz M, Primeau F, Belzile E (2002) Delirium predicts 12-month mortality. Arch Intern Med 162:457–463CrossRef
35.
Ohta T, Waga S, Handa H, Saito I, Takeuchi H, Suzuki J, Takaku A (1974) New grading of level of disordered consciousness (in Japanese) Jpn J Neurosurg 2: 623–627
36.
Paulson CM, Monroe T, McDougall GJ Jr, Fick DM (2016) A family-focused delirium educational initiative with practice and research implications. Gerontol Geriatr Educ 37:4–11CrossRef
37.
Pompei P, Foreman M, Rudberg MA, Inouye SK, Braund V, Cassel CK (1994) Delirium in hospitalized older persons: outcomes and predictors. J Am Geriatr Soc 42:809–815CrossRef
38.
Prakanrattana U, Prapaitrakool S (2007) Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care 35:714–719PubMed
39.
Rice KL, Bennett M, Gomez M, Theall KP, Knight M, Foreman MD (2011) Nurses’ recognition of delirium in the hospitalized older adult. Clin Nurse Spec 25:299–311CrossRef
40.
Rothschild JM, Bates DW, Leape LL (2000) Preventable medical injuries in older patients. Arch Intern Med 160:2717–2728CrossRef
41.
Siddiqi N, Cheater F, Collinson M, Farrin A, Forster A, George D, Godfrey M, Graham E, Harrison J, Heaven A, Heudtlass P, Hulme C, Meads D, North C, Sturrock A, Young J (2016) The PiTSTOP study: a feasibility cluster randomized trial of delirium prevention in care homes for older people. Age Ageing 45:652–661PubMedPubMedCentral
42.
Speed G (2015) The impact of a delirium educational intervention with intensive care unit nurses. Clin Nurse Spec 29:89–94CrossRef
43.
Sundararajan V, Quan H, Halfon P, Fushimi K, Luthi JC, Burnand B, Ghali WA, International Methodology Consortium for Coded Health I (2007) Cross-national comparative performance of three versions of the ICD-10 Charlson index. Med Care 45:1210–1215CrossRef
44.
Vasilevskis EE, Han JH, Hughes CG, Ely EW (2012) Epidemiology and risk factors for delirium across hospital settings. Best Pract Res Clin Anaesthesiol 26:277–287CrossRef
45.
Witlox J, Eurelings LS, de Jonghe JF, Kalisvaart KJ, Eikelenboom P, van Gool WA (2010) Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA 304:443–451CrossRef
Metadata
Title
Quality of care in hospitalized cancer patients before and after implementation of a systematic prevention program for delirium: the DELTA exploratory trial
Authors
Asao Ogawa
Yasuyuki Okumura
Daisuke Fujisawa
Hiroyuki Takei
Chiyuki Sasaki
Kei Hirai
Yusuke Kanno
Kensuke Higa
Yasuhiko Ichida
Asuko Sekimoto
Chie Asanuma
Publication date
01-02-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 2/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4341-8

Other articles of this Issue 2/2019

Supportive Care in Cancer 2/2019 Go to the issue

Original Article

Content analysis of rehabilitation goals for patients following non-surgical head and neck cancer treatment

Original Article

Early platelet variation during concomitant chemo-radiotherapy predicts adjuvant temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma patients

Review Article

Sensory preferences of supplemented food products among cancer patients: a systematic review

Original Article

Patients’ experience of lung cancer care coordination: a quantitative exploration

Review Article

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review

Original Article

Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits